Abstract:e13778 Background: While Africa makes up 17% of the total world population, it has 24% of the global disease burden. Furthermore, although Africa is rich in genomic diversity, Africans make up <4% of the patients in global pharma studies and 1% of the global genomic database. In 2020 there were only 63 African patients in Roche global clinical trials. The Africa AIR Site Alliance model was undertaken to address the growing importance of interventional clinical trials with advanced diagnostics and therapies in Africa, as well as the lack of representation of the African population in global datasets, which contribute to continued health disparities, poor outcomes and existing inequities. Methods: In countries with a legal research framework, no clinical trial holds and who have conducted at least 1 Roche clinical trial during the last 5 years potential Centers of Excellence for the Africa AIR Site Alliance were identified. For patients, sites had invoiceable services to ensure they were supported and could potentially include education about clinical trial participation, reasonable travel and accommodation, or covering the cost of missed work or childcare. Sites participated in training on how to conduct clinical trials, including opportunities to share best practices across sites. Results: Four pilot countries were selected and had Centers of Excellence identified to work as partners with Roche for global clinical trials: Morocco (Marrakech University Hospital Center), Nigeria (University College Hospital Ibadan), Kenya (University of Nairobi Institute of Tropical and Infectious Diseases) and South Africa (Limpopo Cancer Research Institute). After entering the Africa AIR Site Alliance, sites reported consistent application of standard operating procedures and manuals, trained and empowered staff, increased organization and appropriate patient support, plus knowledge and experience with industry trials. Sites are successfully participating in an increased number of global clinical trials in various therapeutic areas with 23 patients enrolled at the Africa AIR Site Alliance sites in oncology and ophthalmology studies. Conclusions: The Africa AIR Site Alliance model is a groundbreaking initiative that has the potential to revolutionize clinical research in Africa with a positive long-term impact on the African healthcare ecosystem and clinical care delivery. Limited diversity and representation in genomic, safety and efficacy data have hampered scientific and medical progress on the continent. The Africa AIR Site Alliance provides critical support, knowledge and skills for conducting clinical trials and assists in removing barriers for underrepresented patients to participate in these trials. Future work will focus on expanding to additional countries in Africa and creating a robust network of Centers of Excellence for innovative research.

H3Africa partnerships to empower clinical research sites to generate high-quality biological samples

Building blocks for better biorepositories in Africa

Development of Bioinformatics Infrastructure for Genomics Research

H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa

Advancing inclusive research (AIR) in Africa: Strengthening healthcare systems to enhance access on the continent through the Africa AIR site alliance model.

The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria

Ethical considerations for biobanking and use of genomics data in Africa: a narrative review

Developing reproducible bioinformatics analysis workflows for heterogeneous computing environments to support African genomics

Using a multiple-delivery-mode training approach to develop local capacity and infrastructure for advanced bioinformatics in Africa

An NCI perspective on creating sustainable biospecimen resources

Establishing a Biologic Specimens Repository for Reproductive Clinical Trials: Technical Aspects

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe

Setting up a state‐of‐the‐art laboratory in resource limited settings: A case study of the biomedical science research and training centre in Northeast Nigeria

Data sharing practices in collaborative human genomic research in low- and middle-income countries: A systematic review protocol

Establishing African genomics and bioinformatics programs through annual regional workshops

Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda

The V-BRCH Project: Strengthening HIV Research Capacity in Nigeria through Intensive Workshops in Implementation Science and Grant Writing

Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach

The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmes

The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan Africa

Designing a course model for distance-based online bioinformatics training in Africa: The H3ABioNet experience